ERBB2 and breast carcinoma: To determine the mechanisms of action of 1E5 in HER2-positive breast cancer, we measured mRNA and protein levels of LXR and selected LXR target genes upon treatment with DMSO, GW (10 μM), and 1E5 (10 μM).